Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with Sickle Cell Disease
Calhoun C, Colvin R, Verlekar A, Lassa-Claxton S, Cole F, Hulbert M. Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with Sickle Cell Disease. Blood 2016, 128: 315. DOI: 10.1182/blood.v128.22.315.315.Peer-Reviewed Original ResearchSt. Louis Children's HospitalSickle cell diseaseLower hospitalization ratesHematopoietic stem cell transplantPopulation of childrenStem cell transplantHospitalization ratesSevere genotypeCell diseaseGenotype groupsHydroxyurea useTotal hospitalizationsCell transplantOutpatient encountersVaso-occlusive pain episodesHU treatmentStudy periodImpact of hydroxyureaMore outpatient encountersReduced hospitalization ratesHigher hospitalization ratesRate of hospitalizationICD-9 codesUnrelated medical conditionsGenotypes of SCD